Navigation Links
Fuel cells help make noisy, hot generators a thing of the past
Date:12/12/2007

syngas as the co-reactant in place of hydrogen. Gas phase operation of the process allows for a significant increase in throughput and decrease in operating pressure compared with conventional technology. The process doesn't require consumables or periodic regeneration. The system was developed with funding from the U.S. Army Tank Automotive Research, Development and Engineering Center.

Fuel cells combine hydrogen and oxygen to produce electrical energy with water and heat as by-products. The process is clean, quiet and highly efficient - potentially up to three times more efficient than internal combustion engines. Envisioned benefits include reduced emissions, increased reliability, multi-fuel capability, durability and ease of maintenance.


'/>"/>

Contact: Christy Lambert
christy.lambert@pnl.gov
509-375-3732
DOE/Pacific Northwest National Laboratory  
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. ESF EURYI award winner aims to stop cancer cells reading their own DNA
2. Newly created cancer stem cells could aid breast cancer research
3. AIDS interferes with stem cells in the brain
4. Clemson scientists shed light on molecules in living cells
5. Social habits of cells may hold key to fighting diseases
6. UF scientists reveal how dietary restriction cleans cells
7. Human derived stem cells can repair rat hearts damaged by heart attack
8. Scientists identify embryonic stem cells by appearance alone
9. Cells united against cancer
10. Pittsburgh scientists identify human source of stem cells with potential to repair muscle
11. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fuel cells help make noisy, hot generators a thing of the past
Fuel cells help make noisy, hot generators a thing of the past
(Date:11/20/2009)...duction of a single bacterial gene into yeast, res...e Netherlands achieved three improvements in bioet... ,More ethanol, less acetate and elimination of th...on was published in the scientific journal Applie... , Bioethanol is made by the yeast Saccharomyces ...
(Date:11/20/2009)...ctive pulmonary disease (COPD), a respiratory dise...ema, is the fourth leading cause of death worldwid...searchers have yet to find any real treatment or c...t The University of Western Ontario in London, Can...ew insight into the disease. , Parraga is a ...
(Date:11/19/2009)...ly 15,000 years ago, at the end of the last ice ag...s including such iconic creatures as mammoths, ma...eavers began their precipitous slide to extinctio...g a land whose diversity of large animals equaled ...ns then or now, an entirely novel ecosystem emerge...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Gaining a better picture of lung disease 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Medical Safety Net in Florida to Strengthen with Recent Grants 49925 1Medical Safety Net in Florida to Strengthen with Recent Grants 49925 2First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 1First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 2First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 3Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 1Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 2Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 3
...eveloped a novel method for attaching small molecu... then are used to capture large biomolecules. By ...olecules, researchers can make the technique appli...drugs, chemical warfare agents, and environmental ... to identify synthetic biomolecules that recognize...
...blisher for Physics, Mathematics and Computer Scie...e CERN and DESY high-energy physics laboratories. ...trally cover article-processing charges for all re...r-reviewed open access journal, PMC Physics A. , ...University of Oxford and Royal Holloway and was la...
...staple for people planning their day. Now with the...to broaden daily forecasts to include predictions ... some parts of the world. , Some scientists predi...orecasts of air pollution near the ground, where i...Such a system could prove useful in efforts to imp...
Other Biology News:Biocapture surfaces produced for study of brain chemistry 2Top physics laboratories sign up to open access with PhysMath Central 2Air quality forecasts see future in space 2Air quality forecasts see future in space 3
(Date:11/19/2009)...ire-FirstCall/ -- Omeros Corporation (Nasdaq: OME...r the third quarter ended September 30, 2009. For ...reported a net loss of $3.9 million, or $1.34 per ...or $2.54 per share, for the same period in 2008. F...ompany reported a net loss of $15.5 million, or $5...
(Date:11/19/2009)...HAM, Mass., Nov. 19 Arlington Medi...at the leading driver of antibiotic selection in n...tivity against gram-positive and gram-negative pat...ause nosocomial pneumonia, surveyed European physi...hat provide appropriate coverage against common pa...
(Date:11/19/2009)... honored by latest award for revolutionary hearing...) November 16, 2009 -- Popular Science Magazine ha...aid from InSound Medical a winner of its coveted B...ry.    Chosen from thousands o...e hearing canal for up to four months while provid...
(Date:11/18/2009)...-dotted postage stamp that can sniff out poisonous... , As reported in the Sept. 13 issue of the jour...am at the University of Illinois have developed an...c industrial chemicals (TICs) that is simple, fast... This sensor array could be useful in detecting hi...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...vests to advance expanding pipeline of products to... PARIS, Dec. 12 Fovea Pharmaceuticals SA, a,bioph... for the treatment,of ophthalmic diseases announce... financing from a strong, international syndicate ...al Partners (Naarden, The,Netherlands). All existi...
... cars are reaching commercial viability in todays ...eir promise, even scientists have struggled to exp...e proton exchange membrane really works. , How... of Energys Ames Laboratory has offered a new mode...he membranes structure and how it functions. And a...
...ymbol: MS, EDMONTON, Dec. 11 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) has,reviewed data from the...III,clinical trial of MBP8298 for the treatment of... trial continue., This was the first of several r...
Other Biology Technology:Fovea Pharmaceuticals Completes EUR30M Series B Financing 2Fovea Pharmaceuticals Completes EUR30M Series B Financing 3Fovea Pharmaceuticals Completes EUR30M Series B Financing 4Ames Laboratory researchers solve fuel-cell membrane structure conundrum 2BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Mouse Anti-Human STAU2 Monoclonal Antibody, Unconjugated, Clone 6F9 from Abnova Corporation
Mouse Anti-Human NR2F2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Mouse Anti-Human YARS Monoclonal Antibody, Unconjugated, Clone 2F3 from Abnova Corporation
Biology Products: